Investing.com - Hims & Hers said on Monday that it may stop selling legal copies of a popular weight-loss drug made by Denmark's Novo Nordisk (NYSE: NVO), sending shares in the U.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback